Mariano Larman, MD

Original Contribution

Long-Term Clinical Performance of Paclitaxel-Eluting Stents Coated With a Bioactive Polymer (P-5) Containing a Triflusal Derivative: Results of the REWAC Registry

07/30/2013

José Ramón Rumoroso , MD;

Antoni Serra , MD, PhD;

Eulogio García , MD;

José Javier Zueco , MD;

Mariano Larman , MD;

José Moreu , MD;

Jordi Guarinos , MD;

María Rosario Ortas , MD;

Basaganyas Puigfel , MD;

Adolfo Rincón , MD;

Karagounis Ioannidis , MD;

Núria Piqué , PhD;

Under routine clinical practice, the implantation of paclitaxel-eluting stents coated with P-5 is associated with favorable clinical outcomes in both the short and long term (2 years) in patients with coronary artery disease.

Under routine clinical practice,...

07/30/2013

Journal of Invasive Cardiology

Tips and Techniques

Transradial Crossover Balloon Occlusion Technique for Primary Access Hemostasis During Transcatheter Aortic Valve Replacement: Initial Experience With the Oceanus 140 cm and 200 cm Balloon Catheters

07/31/2020

Antonio Colombo , MD;

Ramiro Trillo , MD;

Cesar Moris , MD, PhD;

Jose Maria Hernandez , MD;

Ignacio Amat-Santos , MD;

Azeem Latib , MD, BCh, MBBCh;

Georgios Tzanis , MD;

Benjamin Faurie , MD, PhD;

Josep Rodés-Cabau , MD, PhD;

Marta Duran-Priu , PhD;

Eduard Fernandez-Nofrerias , MD;

Jean-Michel Paradis , MD;

Lluis Duocastella , PhD;

Manel Sabaté , MD, PhD;

Lucia Junquera , MD;

Andres Iniguez-Romo , MD, PhD;

Luis Nombela-Franco , MD;

Pilar Jimenez-Quevedo , MD;

Mariano Larman , MD;

Marina Urena , MD;

Antonio Munoz-Garcia , MD;

Bruno Garcia Del Blanco , MD;

Ander Regueiro , MD;

Victoria Vilalta , MD;

The crossover balloon occlusion technique (CBOT) facilitates primary access hemostasis in patients undergoing transfemoral transcatheter aortic valve replacement. It is usually performed through the contralateral femoral artery. The aim of...

The crossover balloon occlusion...

07/31/2020

Journal of Invasive Cardiology